322 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

300583

Shandong Sito Bio-technology
CN¥13.04-4.2%-20.9%CN¥2.5bn/aPE74.2xE28.9%3.5%

301111

Guangdong Lifestrong Pharmacy
CN¥15.48-2.9%-26.6%CN¥2.5bn/aPE81.4xn/a0.6%

688137

Novoprotein Scientific
CN¥35.30-3.6%-38.1%CN¥2.5bn/aPS18.2xn/a1.4%

300289

Beijing Leadman BiochemistryLtd
CN¥4.48-0.9%-23.2%CN¥2.5bn/aPE562.1xn/a0.2%

603811

Zhejiang Cheng Yi Pharmaceutical
CN¥7.57-3.1%-42.1%CN¥2.5bn/aPE15.9xn/a2.6%

600080

Ginwa Enterprise (Group)
CN¥6.78-0.3%-10.4%CN¥2.4bn/aPS4.2xn/a0%

600774

Hanshang Group
CN¥8.49-1.2%-31.1%CN¥2.4bn/aPE49.4xn/a0%

300016

Beijing Beilu Pharmaceutical
CN¥4.970.8%-31.4%CN¥2.4bn/aPS2.7xn/a0%

300147

Xiangxue PharmaceuticalLtd
CN¥3.52-5.9%-37.0%CN¥2.4bn/aPS1xn/a0%

790

Chengdu huasun technology group
CN¥3.80-2.3%-25.3%CN¥2.4bn/aPE89.3xn/a0.3%

300149

ChemPartner PharmaTechLtd
CN¥4.74-3.3%-43.7%CN¥2.4bn/aPS2.1xn/a0%

518

Jiangsu Sihuan Bioengineering
CN¥2.23-3.5%-18.0%CN¥2.4bn/aPS9.8xn/an/a

300254

ShanXi C&Y Pharmaceutical GroupLTD
CN¥9.12-0.4%40.3%CN¥2.4bn/aPE48.3xn/a0%

688221

Frontier Biotechnologies
CN¥6.25-2.2%-47.5%CN¥2.4bn/aPS18.4xn/an/a

300534

Gansu Longshenrongfa Pharmaceutical IndustryLTD
CN¥7.68-1.0%-27.7%CN¥2.4bn/aPE36.5xn/a0.3%

300878

Zhejiang Wecome Pharmaceutical
CN¥16.24-5.6%-31.5%CN¥2.3bn/aPS4.4xn/a1.5%

2365

Qianjiang Yongan Pharmaceutical
CN¥7.77-0.8%-20.4%CN¥2.3bn/aPE1653.8xn/a1.3%

504

Landfar Bio-medicine
CN¥7.00-1.4%-42.9%CN¥2.3bn/aPS18xn/an/a

2566

Jilin Jian Yisheng Pharmaceutical
CN¥6.83-0.3%-20.5%CN¥2.3bn/aPE26xn/a2.2%

600721

Xinjiang Bai Hua Cun Pharma TechLtd
CN¥5.75-1.0%-12.3%CN¥2.2bn/aPE81.5xn/an/a

300813

Zhejiang Tailin BioEngineeringLtd
CN¥19.63-4.9%-33.0%CN¥2.2bn/aPE268.9xn/a0.5%

300966

Hubei Goto BiopharmLtd
CN¥18.96-5.3%-20.5%CN¥2.2bn/aPE97xn/a0.08%

2693

Hainan Shuangcheng Pharmaceuticals
CN¥5.12-4.8%-18.5%CN¥2.2bn/aPS10.8xn/a0%

2873

Guiyang Xintian PharmaceuticalLtd
CN¥9.66-5.6%-33.9%CN¥2.1bn/aPE29.6xE20.4%0.7%
Page 12 of 14
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.